Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Anesthesiology
Volume 2017, Article ID 5796409, 4 pages
https://doi.org/10.1155/2017/5796409
Case Report

An Undiagnosed Paraganglioma in a 58-Year-Old Female Who Underwent Tumor Resection

1Department of Anesthesiology, Duke University Medical Center, Box 3823, Durham, NC 27710, USA
2Critical Care Medicine, Department of Anesthesiology, Duke University Medical Center, Box 3823, Durham, NC 27710, USA
3General, Vascular, Transplant Division, Department of Anesthesiology, Duke University Medical Center, Box 3823 Durham, NC 27710, USA

Correspondence should be addressed to William C. Fox; ude.ekud.md@xof.c.mailliw

Received 17 June 2017; Accepted 18 September 2017; Published 15 October 2017

Academic Editor: Maurizio Marandola

Copyright © 2017 William C. Fox et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Lin, S. E. Carty, and W. F. Young, “Paragangliomas: epidemiology, clinical presentation, diagnosis, and histology,” Uptodate.com, 2016, http://www.uptodate.com/contents/paragangliomas-epidemiology-clinical-presentation-diagnosis-and-histology. View at Google Scholar
  2. C. M. Beard, S. G. Sheps, L. T. Kurland, J. A. Carney, and J. T. Lie, “Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979,” Mayo Clinic Proceedings, vol. 58, no. 12, pp. 802–804, 1983. View at Google Scholar · View at Scopus
  3. C. C. Boedeker, H. P. H. Neumann, W. Maier, B. Bausch, J. Schipper, and G. J. Ridder, “Malignant head and neck paragangliomas in SDHB mutation carriers,” Otolaryngology—Head and Neck Surgery, vol. 137, no. 1, pp. 126–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Erickson, Y. C. Kudva, M. J. Ebersold et al., “Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 11, pp. 5210–5216, 2001. View at Publisher · View at Google Scholar
  5. O. F. M. Sellevold, J. Raeder, and R. Stenseth, “Undiagnosed Phaeochromocytoma in the Perioperative Period: Case Reports,” Acta Anaesthesiologica Scandinavica, vol. 29, no. 5, pp. 474–479, 1985. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Sutton, S. Sheps, and J. Lie, “Prevalence of clinically unsuspected pheochromocytoma. review of a 50-year autopsy series,” Mayo Clinic Proceedings, vol. 56, no. 6, pp. 354–360, 1981. View at Publisher · View at Google Scholar
  7. M. A. Kinney, M. E. Warner, J. A. vanHeerden et al., “Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection,” Anesthesia & Analgesia, vol. 91, no. 5, pp. 1118–1123, 2000. View at Publisher · View at Google Scholar
  8. H. Bruynzeel, R. A. Feelders, T. H. N. Groenland et al., “Risk factors for hemodynamic instability during surgery for pheochromocytoma,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 2, pp. 678–685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. M. Altura, B. T. Altura, and A. Carella, “Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels,” Canadian Journal of Physiology and Pharmacology, vol. 65, no. 4, pp. 729–745, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. M. F. James and L. Cronjé, “Pheochromocytoma crisis: The use of magnesium sulfate,” Anesthesia & Analgesia, vol. 99, no. 3, pp. 680–686, 2004. View at Publisher · View at Google Scholar · View at Scopus